Search
for
Sort by
Research 151–180 of 1000+
- Blinding in Placebo-Controlled Trials
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- A Case Report of Autoimmune Hemolytic Anemia with Deep Vein Thrombosis in a 16-year-old Girl - Is It Systemic Lupus Erythematosus?
- Tufted Hair Folliculitis Decalvans as a Clinical Diagnostic Sign
- The Specific Dermatoses of Pregnancy
- In vitro expansion of human mesenchymal stem cells and hepatocytes using purified platelet derived growth factors, a potential therapeutic modality for liver fibrosis
- Medications
- Therapies
- Blinding in Placebo-Controlled Trials
- Classified Advertising
- LITERATURE REVIEW
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- The role of lymphocytes in the development and treatment of alopecia areata
- How to diagnose a lipodystrophy syndrome
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
- Acquired scalp alopecia. Part I: A review
- Treatment strategies for alopecia
- The Clinical Presentation of Systemic Lupus Erythematosus
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls
- Alopecia areata: A review
- Stem cells and aberrant signaling of molecular systems in skin aging
- INTERFERONS IN DERMATOLOGY
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites